EPO Eprex 4000iu – Sold Per Pen

Medical Disclaimer

The information provided on this website, including dosages, is for general informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication.

EPO Eprex – Sold Per Pen

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma, or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

Eprex: Epoetin alfa belongs to the class of medications known as erythropoiesis regulating hormones. It is used to increase the production of red blood cells.

R710.00

Availability: In stock

Images are for illustrative purposes only

Description

EPO Eprex is a brand name for a medication containing the active ingredient epoetin alfa, which is a synthetic form of erythropoietin, a hormone produced by the kidneys that stimulates the production of red blood cells in the bone marrow. It is used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer undergoing chemotherapy, or those receiving zidovudine for HIV treatment.

Here’s how EPO Eprex is typically used:

1. **Injection**: EPO Eprex is administered by injection, usually subcutaneously (under the skin) or intravenously (into a vein). The route of administration and dosage may vary depending on the patient’s condition and response to treatment

2. **Dosage**: The dosage of EPO Eprex is individualized based on factors such as the patient’s weight, hemoglobin levels, and the underlying cause of anemia. It is important to follow the prescribed dosage and administration instructions provided to ensure safe and effective treatment.

3. **Frequency**: The frequency of EPO Eprex injections may vary depending on the severity of anemia and the patient’s response to treatment. In some cases, it may be administered several times a week, while in others, it may be given less frequently. It is essential to adhere to the recommended dosing schedule to maintain optimal hemoglobin levels.

4. **Monitoring**: Regular monitoring of hemoglobin levels and other blood parameters is necessary during treatment with EPO Eprex to assess the response to therapy and adjust the dosage as needed. Some may also monitor for signs of adverse effects or complications associated with EPO therapy, such as hypertension or thromboembolic events.

5. **Duration**: The duration of treatment with EPO Eprex may vary depending on the underlying cause of anemia and the patient’s overall health status. In some cases, treatment may be short-term to correct anemia temporarily, while in others, it may be long-term to manage chronic anemia associated with conditions such as CKD.

Common side effects of EPO Eprex may include hypertension, headache, dizziness, nausea, vomiting, injection site reactions, and flu-like symptoms.

In summary, EPO Eprex (epoetin alfa) is a medication used to treat anemia by stimulating the production of red blood cells in the bone marrow. It is administered by injection and individualized based on the patient’s condition and response to treatment.

Additional information

Chemical-composition

Treat anemia – Epoetin alfa

Strength

4000iu

Pack-size

1 x 0.4ml

Laboratory

Pharmaceuticals

Shopping Cart
EPO Eprex 4000iu – Sold Per Pen
R710.00

Availability: In stock

Scroll to Top